Design, synthesis and evaluation of isaindigotone derivatives as dual inhibitors for acetylcholinesterase and amyloid beta aggregation. 2012

Jin-Wu Yan, and Yan-Ping Li, and Wen-Jie Ye, and Shuo-Bin Chen, and Jin-Qiang Hou, and Jia-Heng Tan, and Tian-Miao Ou, and Ding Li, and Lian-Quan Gu, and Zhi-Shu Huang
School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou 510006, PR China.

A series of isaindigotone derivatives and analogues were designed, synthesized and evaluated as dual inhibitors of cholinesterases (ChEs) and self-induced β-amyloid (Aβ) aggregation. The synthetic compounds had IC(50) values at micro or nano molar range for cholinesterase inhibition, and some compounds exhibited strong inhibitory activity for AChE and high selectivity for AChE over BuChE, which were much better than the isaindigotone derivatives previously reported by our group. Most of these compounds showed higher self-induced Aβ aggregation inhibitory activity than a reference compound curcumin. The structure-activity relationship studies revealed that the derivatives with higher inhibition activity on AChE also showed higher selectivity for AChE over BuChE. Compound 6c exhibiting excellent inhibition for both AChE and self-induced Aβ aggregation was further studied using CD, EM, molecular docking and kinetics.

UI MeSH Term Description Entries
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D011799 Quinazolines A group of aromatic heterocyclic compounds that contain a bicyclic structure with two fused six-membered aromatic rings, a benzene ring and a pyrimidine ring. Quinazoline
D002800 Cholinesterase Inhibitors Drugs that inhibit cholinesterases. The neurotransmitter ACETYLCHOLINE is rapidly hydrolyzed, and thereby inactivated, by cholinesterases. When cholinesterases are inhibited, the action of endogenously released acetylcholine at cholinergic synapses is potentiated. Cholinesterase inhibitors are widely used clinically for their potentiation of cholinergic inputs to the gastrointestinal tract and urinary bladder, the eye, and skeletal muscles; they are also used for their effects on the heart and the central nervous system. Acetylcholinesterase Inhibitor,Acetylcholinesterase Inhibitors,Anti-Cholinesterase,Anticholinesterase,Anticholinesterase Agent,Anticholinesterase Agents,Anticholinesterase Drug,Cholinesterase Inhibitor,Anti-Cholinesterases,Anticholinesterase Drugs,Anticholinesterases,Cholinesterase Inhibitors, Irreversible,Cholinesterase Inhibitors, Reversible,Agent, Anticholinesterase,Agents, Anticholinesterase,Anti Cholinesterase,Anti Cholinesterases,Drug, Anticholinesterase,Drugs, Anticholinesterase,Inhibitor, Acetylcholinesterase,Inhibitor, Cholinesterase,Inhibitors, Acetylcholinesterase,Inhibitors, Cholinesterase,Inhibitors, Irreversible Cholinesterase,Inhibitors, Reversible Cholinesterase,Irreversible Cholinesterase Inhibitors,Reversible Cholinesterase Inhibitors
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004593 Electrophorus A genus of fish, in the family GYMNOTIFORMES, capable of producing an electric shock that immobilizes fish and other prey. The species Electrophorus electricus is also known as the electric eel, though it is not a true eel. Eel, Electric,Electric Eel,Electrophorus electricus
D006736 Horses Large, hoofed mammals of the family EQUIDAE. Horses are active day and night with most of the day spent seeking and consuming food. Feeding peaks occur in the early morning and late afternoon, and there are several daily periods of rest. Equus caballus,Equus przewalskii,Horse, Domestic,Domestic Horse,Domestic Horses,Horse,Horses, Domestic
D000110 Acetylcholinesterase An enzyme that catalyzes the hydrolysis of ACETYLCHOLINE to CHOLINE and acetate. In the CNS, this enzyme plays a role in the function of peripheral neuromuscular junctions. EC 3.1.1.7. Acetylcholine Hydrolase,Acetylthiocholinesterase,Hydrolase, Acetylcholine
D000470 Alkaloids Organic nitrogenous bases. Many alkaloids of medical importance occur in the animal and vegetable kingdoms, and some have been synthesized. (Grant & Hackh's Chemical Dictionary, 5th ed) Alkaloid,Plant Alkaloid,Plant Alkaloids,Alkaloid, Plant,Alkaloids, Plant
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

Jin-Wu Yan, and Yan-Ping Li, and Wen-Jie Ye, and Shuo-Bin Chen, and Jin-Qiang Hou, and Jia-Heng Tan, and Tian-Miao Ou, and Ding Li, and Lian-Quan Gu, and Zhi-Shu Huang
July 2008, Bioorganic & medicinal chemistry letters,
Jin-Wu Yan, and Yan-Ping Li, and Wen-Jie Ye, and Shuo-Bin Chen, and Jin-Qiang Hou, and Jia-Heng Tan, and Tian-Miao Ou, and Ding Li, and Lian-Quan Gu, and Zhi-Shu Huang
May 2024, Bioorganic & medicinal chemistry letters,
Jin-Wu Yan, and Yan-Ping Li, and Wen-Jie Ye, and Shuo-Bin Chen, and Jin-Qiang Hou, and Jia-Heng Tan, and Tian-Miao Ou, and Ding Li, and Lian-Quan Gu, and Zhi-Shu Huang
November 2013, Yao xue xue bao = Acta pharmaceutica Sinica,
Jin-Wu Yan, and Yan-Ping Li, and Wen-Jie Ye, and Shuo-Bin Chen, and Jin-Qiang Hou, and Jia-Heng Tan, and Tian-Miao Ou, and Ding Li, and Lian-Quan Gu, and Zhi-Shu Huang
December 2023, Journal of enzyme inhibition and medicinal chemistry,
Jin-Wu Yan, and Yan-Ping Li, and Wen-Jie Ye, and Shuo-Bin Chen, and Jin-Qiang Hou, and Jia-Heng Tan, and Tian-Miao Ou, and Ding Li, and Lian-Quan Gu, and Zhi-Shu Huang
October 2016, Bioorganic & medicinal chemistry letters,
Jin-Wu Yan, and Yan-Ping Li, and Wen-Jie Ye, and Shuo-Bin Chen, and Jin-Qiang Hou, and Jia-Heng Tan, and Tian-Miao Ou, and Ding Li, and Lian-Quan Gu, and Zhi-Shu Huang
January 2011, Bioorganic & medicinal chemistry,
Jin-Wu Yan, and Yan-Ping Li, and Wen-Jie Ye, and Shuo-Bin Chen, and Jin-Qiang Hou, and Jia-Heng Tan, and Tian-Miao Ou, and Ding Li, and Lian-Quan Gu, and Zhi-Shu Huang
May 2013, Die Pharmazie,
Jin-Wu Yan, and Yan-Ping Li, and Wen-Jie Ye, and Shuo-Bin Chen, and Jin-Qiang Hou, and Jia-Heng Tan, and Tian-Miao Ou, and Ding Li, and Lian-Quan Gu, and Zhi-Shu Huang
February 2009, European journal of medicinal chemistry,
Jin-Wu Yan, and Yan-Ping Li, and Wen-Jie Ye, and Shuo-Bin Chen, and Jin-Qiang Hou, and Jia-Heng Tan, and Tian-Miao Ou, and Ding Li, and Lian-Quan Gu, and Zhi-Shu Huang
December 2017, European journal of medicinal chemistry,
Jin-Wu Yan, and Yan-Ping Li, and Wen-Jie Ye, and Shuo-Bin Chen, and Jin-Qiang Hou, and Jia-Heng Tan, and Tian-Miao Ou, and Ding Li, and Lian-Quan Gu, and Zhi-Shu Huang
November 2014, Bioorganic & medicinal chemistry,
Copied contents to your clipboard!